{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:10:41Z","timestamp":1769231441431,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:00:00Z","timestamp":1211241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:00:00Z","timestamp":1211241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/ncprheum0818","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T12:01:13Z","timestamp":1211284873000},"page":"381-386","source":"Crossref","is-referenced-by-count":57,"title":["Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus"],"prefix":"10.1038","volume":"4","author":[{"given":"Julius","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,20]]},"reference":[{"key":"BFncprheum0818_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1085-9489.2005.0010206.x","volume":"10","author":"PJ Dyck","year":"2005","unstructured":"Dyck PJ  et al. (2005) History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation. J Peripher Nerv Syst 10: 158\u2013173","journal-title":"J Peripher Nerv Syst"},{"key":"BFncprheum0818_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0025-7125(03)00008-7","volume":"87","author":"EM Frohman","year":"2003","unstructured":"Frohman EM (2003) Multiple sclerosis. Med Clin North Am 87: 867\u2013897","journal-title":"Med Clin North Am"},{"key":"BFncprheum0818_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMcp053247","volume":"354","author":"LJ Balcer","year":"2006","unstructured":"Balcer LJ (2006) Clinical practice. Optic neuritis. N Engl J Med 354: 1273\u20131280","journal-title":"N Engl J Med"},{"key":"BFncprheum0818_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/archopht.121.2.292","volume":"121","author":"RW Beck","year":"2003","unstructured":"Beck RW  et al. (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121: 944\u2013999","journal-title":"Arch Ophthalmol"},{"key":"BFncprheum0818_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","volume":"5","author":"A Charil","year":"2006","unstructured":"Charil A  et al. (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of \u201cno better explanation\u201d. Lancet Neurol 5: 841\u2013852","journal-title":"Lancet Neurol"},{"key":"BFncprheum0818_CR6","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F  et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059\u20132069","journal-title":"Brain"},{"key":"BFncprheum0818_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","volume":"180","author":"H Link","year":"2006","unstructured":"Link H and Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180: 17\u201328","journal-title":"J Neuroimmunol"},{"key":"BFncprheum0818_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ana.21226","volume":"62","author":"C Salvarani","year":"2007","unstructured":"Salvarani C  et al. (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62: 442\u2013451","journal-title":"Ann Neurol"},{"key":"BFncprheum0818_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","volume":"47","author":"RT Johnson","year":"1968","unstructured":"Johnson RT and Richardson EP (1968) The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 47: 337\u2013369","journal-title":"Medicine (Baltimore)"},{"key":"BFncprheum0818_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/art.22540","volume":"57","author":"J Birnbaum","year":"2007","unstructured":"Birnbaum J and Kerr D (2007) Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arthritis Rheum 57: 347\u2013351","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0818_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/01.icu.0000188361.52166.93","volume":"16","author":"MK Mathews","year":"2005","unstructured":"Mathews MK (2005) Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol 16: 341\u2013345","journal-title":"Curr Opin Ophthalmol"},{"key":"BFncprheum0818_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM  et al. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485\u20131489","journal-title":"Neurology"},{"key":"BFncprheum0818_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM  et al. (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107\u20131114","journal-title":"Neurology"},{"key":"BFncprheum0818_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA  et al. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473\u2013477","journal-title":"J Exp Med"},{"key":"BFncprheum0818_CR15","first-page":"78","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ  et al. (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78\u201383","journal-title":"Arch Neurol"},{"key":"BFncprheum0818_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","volume":"44","author":"S Ferreira","year":"2005","unstructured":"Ferreira S  et al. (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand. Rheumatology (Oxford) 44: 434\u2013442","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0818_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM  et al. (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805\u2013815","journal-title":"Lancet Neurol"},{"key":"BFncprheum0818_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM and Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7: 173\u2013182","journal-title":"Curr Treat Options Neurol"},{"key":"BFncprheum0818_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF  et al. (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125: 1450\u20131461","journal-title":"Brain"},{"key":"BFncprheum0818_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA  et al. (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270\u20131272","journal-title":"Neurology"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0818","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:12:25Z","timestamp":1684444345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,20]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BFncprheum0818"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0818","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,20]]}}}